Desloratadine Patent Expiration
Desloratadine is used for treating symptoms of allergic rhinitis and chronic idiopathic urticaria. It was first introduced by Organon Llc A Sub Of Organon And Co
Desloratadine Patents
Given below is the list of patents protecting Desloratadine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Clarinex |
US7618649 (Pediatric) | Extended release oral dosage composition |
Jun 19, 2021
(Expired) | Organon |
| Clarinex | US7618649 | Extended release oral dosage composition |
Dec 19, 2020
(Expired) | Organon |
| Clarinex |
US6100274 (Pediatric) | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jan 07, 2020
(Expired) | Organon |
| Clarinex |
US7405223 (Pediatric) | Treating allergic and inflammatory conditions |
Jan 07, 2020
(Expired) | Organon |
| Clarinex | US6100274 | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jul 07, 2019
(Expired) | Organon |
| Clarinex | US7405223 | Treating allergic and inflammatory conditions |
Jul 07, 2019
(Expired) | Organon |
| Clarinex |
US6514520 (Pediatric) | Stabilized antihistamine syrup |
Dec 01, 2018
(Expired) | Merck Sharp Dohme |
| Clarinex | US6514520 | Stabilized antihistamine syrup |
Jun 01, 2018
(Expired) | Merck Sharp Dohme |
| Clarinex |
US5607697 (Pediatric) | Taste masking microparticles for oral dosage forms |
Dec 07, 2015
(Expired) | Organon |
| Clarinex |
US7211582 (Pediatric) | Methods for treating urticaria using descarboethoxyloratadine |
Jun 30, 2015
(Expired) | Merck Sharp Dohme |
| Clarinex |
US7211582 (Pediatric) | Methods for treating urticaria using descarboethoxyloratadine |
Jun 30, 2015
(Expired) | Organon |
| Clarinex |
US7214683 (Pediatric) | Compositions of descarboethoxyloratadine |
Jun 30, 2015
(Expired) | Merck Sharp Dohme |
| Clarinex |
US7214683 (Pediatric) | Compositions of descarboethoxyloratadine |
Jun 30, 2015
(Expired) | Organon |
| Clarinex |
US7214684 (Pediatric) | Methods for the treatment of allergic rhinitis |
Jun 30, 2015
(Expired) | Merck Sharp Dohme |
| Clarinex |
US7214684 (Pediatric) | Methods for the treatment of allergic rhinitis |
Jun 30, 2015
(Expired) | Organon |
| Clarinex | US5607697 | Taste masking microparticles for oral dosage forms |
Jun 07, 2015
(Expired) | Organon |
| Clarinex | US7211582 | Methods for treating urticaria using descarboethoxyloratadine |
Dec 30, 2014
(Expired) | Merck Sharp Dohme |
| Clarinex | US7211582 | Methods for treating urticaria using descarboethoxyloratadine |
Dec 30, 2014
(Expired) | Organon |
| Clarinex | US7214683 | Compositions of descarboethoxyloratadine |
Dec 30, 2014
(Expired) | Merck Sharp Dohme |
| Clarinex | US7214683 | Compositions of descarboethoxyloratadine |
Dec 30, 2014
(Expired) | Organon |
| Clarinex | US7214684 | Methods for the treatment of allergic rhinitis |
Dec 30, 2014
(Expired) | Merck Sharp Dohme |
| Clarinex | US7214684 | Methods for the treatment of allergic rhinitis |
Dec 30, 2014
(Expired) | Organon |
Desloratadine's Family Patents
Explore Our Curated Drug Screens
Desloratadine Generic API Manufacturers
Several generic applications have been filed for Desloratadine. The first generic version for Desloratadine was by Orbion Pharmaceuticals Private Ltd and was approved on Feb 19, 2010. And the latest generic version is by Taro Pharmaceutical Industries Ltd and was approved on May 26, 2016.
Given below is the list of companies who have filed for Desloratadine generic, along with the locations of their manufacturing plants worldwide.
1. BELCHER PHARMS
Belcher Pharmaceuticals Llc has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Belcher Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Apr 19, 2012 |
2. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 3, 2010 |
3. DASH PHARMS
Dash Pharmaceuticals Llc has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Dash Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Feb 10, 2012 |
4. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Mar 8, 2011 |
5. LUPIN PHARMS
Lupin Pharmaceuticals Inc has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Lupin Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 25, 2010 |
6. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Feb 19, 2010 |
7. PERRIGO
Perrigo Llc has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Perrigo.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 22, 2011 |
Manufacturing Plant Locations New
Perrigo's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Perrigo as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
8. REDDYS
Doctor Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Desloratadine. Given below are the details of the strengths of this generic introduced by Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, orally disintegrating | Prescription | ORAL | N/A | Jul 12, 2010 |
| 5MG
(reference standard) | tablet, orally disintegrating | Prescription | ORAL | N/A | Jul 12, 2010 |
9. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Nov 16, 2010 |
10. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Desloratadine. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/ML | solution | Discontinued | ORAL | N/A | May 26, 2016 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||